AAIC 2024 Sessions & Poster Presentations

Learn about the latest study findings from Linus Health

Visit the Linus Health booth #830 and don't miss all of our sessions listed below.
Philadelphia Pennsylvania
Dementia & Technology Pre-Conference

Saturday, July 27


The electronic Person-Specific Outcome Measure (ePSOM) in the US population: What matters to individuals the most about their brain health

Stina Saunders, PhD
Personalized Medicine Lead, Linus Health


Digital Cognitive Screening and ML-Enabled Random Forest Modeling for the Detection of Cognitive Impairment

Ali Jannati, MD, PhD 
Director of Cognitive Science, Linus Health

Sunday, July 28


ORAL PRESENTATION

The electronic Person-Specific Outcome Measure (ePSOM) in the US population: What matters to individuals the most about their brain health

Stina Saunders, PhD
Personalized Medicine Lead, Linus Health

Session #92530
Pennsylvania Convention Center, 201 ABC
8:00–8:45 a.m.

Poster #92530
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • The findings of our study support the notion that treatments in ADRD should be developed with a person-centered approach. We found differences in treatment priorities across the UK and US populations and across sociodemographic groups within these populations.
    We propose measuring "confidence" to assess self-perceived ability in the areas that matter most to the person.

  • We also outline a method to capture and monitor personally meaningful treatment targets.


POSTER

Validation of Clinical Decision Support Recommendations of a Digital Cognitive Assessment by Expert Cognitive Neurologists

Ali Jannati, MD, PhD 
Director of Cognitive Science, Linus Health

Poster #92040
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • Linus Clinical Pathways and the clinical decision support (CDS) recommendations generated by the Linus Health CCE for indications of cognitive impairment were rated as clinically appropriate by five academic, board-certified cognitive neurologists.

  • The findings indicate the clinical utility of the CCE for guiding the PCPs’ approach to diagnosis and management of patients with cognitive impairment.


POSTER

DCTclock metrics differentiate between amnestic and vascular mild cognitive impairment

Ali Jannati, MD, PhD 
Director of Cognitive Science, Linus Health

Poster #89745
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • DCTClock metrics, particularly from the copy clock, show utility for differentiating between amnestic and vascular Mild Cognitive Impairment (MCI).


POSTER

The Digital Clock and Recall is More Equitable and Less Biased than the Mini-Mental State Examination in Terms of Ethnicity

Sean Tobyne, PhD 
VP, Data Science and Analytics, Linus Health

Poster #89963
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • Differences between Hispanics and non-Hispanics were larger for the MMSE in two independent datasets, and significantly so in one of them (not so for race and education).

  • Only MMSE showed differences between these ethnic groups.


POSTER

Digitizing the Trails Making Test for Automatic Detection of Cognitive Impairment: Validity and Reliability

Sean Tobyne, PhD 
VP, Data Science and Analytics, Linus Health

Poster #89997
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • In a new digital Trail Making Test, we show good reliability for time to complete (classic paper metric) and total errors.
    Age trends were consistent with published paper Trail norms across two independent studies, regardless of demographic characteristics.


POSTER

A Brief Digital Neuropsychological Protocol — I: Using Artificial Intelligence Assisted Technology to Assess Process and Errors

David Libon, PhD 
Departments of Geriatrics, Gerontology, and Psychology, School of Osteopathic Medicine, New Jersey institute for Successful Aging, Rowan University

Poster #91441
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • Cluster analysis using a panel of 6 traditional measures classified participants into normal, amnestic MCI, dysexecutive MCI, and dementia groups.

  • Subsequent analyses of error and process variables operationally defined key features associated with amnesia including rapid forgetting, the production of extra-list intrusion errors, profligate responding to recognition foils, and key features underlying reduced executive measures (i.e., perseverations and related errors.)

POSTER

A Brief Digital Neuropsychological Protocol — II: Using Artificial Intelligence to Assess Verbal Serial List Learning Recognition Latency

David Libon, PhD 
Departments of Geriatrics, Gerontology, and Psychology, School of Osteopathic Medicine, New Jersey institute for Successful Aging, Rowan University

Poster #91489
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • Amnestic MCI (aMCI) and dementia (dem) memory clinic patients endorsed more recognition foils than dysexecutive MCI (dMCI) and normal (nl) performing memory clinic patients.  

  • Moreover, for correct recognition responses, latency was slower for aMCI versus dMCI and nl groups; and dementia versus dMCI and nl groups. 

Monday, July 29


ORAL PRESENTATION

Early Identification of Alzheimer's Disease with a Machine Learning-Enabled Digital Cognitive Assessment: Concurrent Detection of Cognitive Impairment and Amyloid-Beta PET Status

Ali Jannati, MD, PhD 
Director of Cognitive Science, Linus Health

Session #93435
Pennsylvania Convention Center, 115 ABC
2:00– 3:30 p.m.

Key takeaways:

  • Identification of both cognitive impairment (CI) and brain pathology is essential for identifying individuals with AD and prioritizing suitable candidates for disease-modifying treatment (DMT).

  • Digital Clock and Recall (DCR) was superior to longer traditional cognitive tests for CI classification and non-inferior to blood-based biomarkers (BBMs) for classifying Aβ PET status.

  • DCR is an efficient means to triage patients for Aβ PET scans and DMT eligibility.


POSTER

A Brief Digital Neuropsychological Protocol — III: Using Artificial Intelligence to Measure Semantic Memory with the ‘Animal’ Fluency Test

David Libon, PhD 
Departments of Geriatrics, Gerontology, and Psychology, School of Osteopathic Medicine, New Jersey institute for Successful Aging, Rowan University

Poster #91512
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • Normal (nl) performing memory clinic patients generated more ‘animal’ exemplars than amnestic MCI (aMCI), dysexecutive MCI (dMCI), and dementia (dem) patient groups.  Both nl and dMCI patients produced a higher, more semantically connected, ‘animal’ Association Index (AI) than dementia patients.  

  • The ‘animal’ AI was associated with increasing numbers of P(r)VLT prototypic recognition foils. 

Wednesday, July 31


DEVELOPING TOPIC POSTER

A Brief Digital Neuropsychological Protocol – IV: Relations Compared to Comprehensive Paper and Pencil Neuropsychological Assessment

Ileana De Anda-Duran, MD
Department of Epidemiology, Tulane University

Poster #95672
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • The memory index constructed using this digitally administered and scored protocol correlated with paper and pencil CVLT-short form delayed free recall and recognition discriminability scores.  

  • The corresponding executive index correlated with paper and pencil executive tests including the WMS-IV Symbol Span; Trails B time to completion, and output on the letter fluency test


POSTER

Integration of a Digital Cognitive Assessment Tool in a Primary Care Setting

Honghuang Lin, PhD
Professor of Medicine, UMass Chan Medical School

Poster #89522
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • The feasibility of integrating Linus Health’s Core Cognitive Evaluation (CCE), a tablet-based digital cognitive assessment, into the workflow of a primary care practice at UMass Memorial Medical Center was evaluated.

  • The results showed that integration of the CCE into a primary care setting was feasible and impacted PCPs’ clinical decision-making, with high patient, caregiver, and provider satisfaction.


POSTER

Digital Cognitive Screening and ML-Enabled Random Forest Modeling for the Detection of Cognitive Impairment

Ali Jannati, MD, PhD 
Director of Cognitive Science, Linus Health

Poster #89936
Pennsylvania Convention Center, Exhibit

Key takeaways:

  • The DCR, a 3-minute digital cognitive assessment, can be used to classify MCI and probable Alzheimer’s dementia with high accuracy, sensitivity, and specificity.

Virtual Posters


The Digital Clock and Recall can predict functional impairment in individuals with and without cognitive impairment and triage those in need of further assessment

Marissa Ciesla, PhD
Senior Clinical Development Scientist, Linus Health

Key takeaways:

  • The DCR can identify individuals in need of further evaluation for functional impairment.

  • The DCR can reliably rule out the need for further assessments of iADLs and ADLs in individuals who are unlikely to be functionally impaired.


Feasibility of the Linus Health's life and health questionnaire in primary-care settings

Marissa Ciesla, PhD
Senior Clinical Development Scientist, Linus Health

Key takeaways:

  • The Life and Health Questionnaire (LHQ) takes less than 5 minutes on average to complete.

  • LHQ completion time is increased to only 6 minutes on average in individuals with lower education level or greater cognitive impairment.

  • Using the LHQ is feasible to screen for lifestyle and psychosocial risk factors related to brain health in primary-care settings.